Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
49,120
Value
$4.44M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202649,120$4.44M0.1%−314−0.6%ReducedHolders
Q1 202649,434$3.96M0.1%−648−1.3%ReducedHolders
Q4 202550,082$4.28M0.1%−828−1.6%ReducedHolders
Q3 202550,910$3.96M0.1%−5,334−9.5%ReducedHolders
Q2 202556,244$4.40M0.1%−2,325−4.0%ReducedHolders
Q1 202558,569$4.24M0.1%−7,229−11.0%ReducedHolders
Q4 202465,798$4.87M0.1%−3,476−5.0%ReducedHolders
Q3 202469,274$4.57M0.1%+3,119+4.7%AddedHolders
Q2 202466,155$6.11M0.2%+2,756+4.3%AddedHolders
Q1 202463,399$6.06M0.2%+6,647+11.7%AddedHolders
Q4 202356,752$4.33M0.1%−1,442−2.5%ReducedHolders
Q3 202358,194$4.03M0.1%−301−0.5%ReducedHolders
Q2 202358,495$5.52M0.2%+892+1.5%AddedHolders
Q1 202357,603$4.77M0.2%+52,443+1,016.3%AddedHolders
Q4 20225,160$385.0K<0.1%−1,312−20.3%ReducedHolders
Q3 20226,472$535.0K<0.1%−1,324−17.0%ReducedHolders
Q2 20227,796$741.0K<0.1%+313+4.2%AddedHolders
Q1 20227,483$876.0K<0.1%−725−8.8%ReducedHolders
Q4 20218,208$1.06M<0.1%+541+7.1%AddedHolders
Q3 20217,667$868.0K<0.1%+3,256+73.8%AddedHolders
Q2 20214,411$457.0K<0.1%+874+24.7%AddedHolders
Q1 20213,537$296.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.